Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Brucella A antigen Antibody (YsT9.1)

Catalog #:   RXX16001 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA
Accession: ChEBI: 84748ChEBI: 59342
Overview

Catalog No.

RXX16001

Species reactivity

Brucellosis

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Brucella A antigen, Brucella cell wall A polysaccharide antigen, Brucella O-PS A-antigen, Brucella abortus O polysaccharide

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

ChEBI: 84748ChEBI: 59342

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

YsT9.1

Data Image
References

Rapid detection of brucellosis by a two-signal vertical flow immunoassay based on sea urchin-like gold nanoparticles., PMID:40474039

Establishment of an indirect ELISA antibody detection method based on the stable expression of LSDV P32 protein in CHO-K1 cells., PMID:40468267

Preparation of a Brucella multiepitope fusion protein based on bioinformatics and its application in serological diagnosis of human brucellosis., PMID:40447804

Preparation and application of specific chicken yolk antibodies in detecting Brucella., PMID:40420953

Immunization of BALB/c mice with detoxified lipopolysaccharide and hydrolytic O-polysaccharide from Brucella melitensis either in combination with or conjugated to tetanus toxoid, enhances protective immune responses against the pathogen., PMID:40383101

Strong immune response and protection against Brucella abortus by Omp25 and BP26 mRNA vaccine candidates., PMID:40349401

Follow-up of antibody changes in brucellosis patients in Gansu, China., PMID:40304471

Development of a competitive ELISA based on Brucella neotomae lipopolysaccharide for detecting brucellosis in livestock., PMID:40280318

Performance characteristics of three Brucella canis serological assays in the United States., PMID:40235569

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity., PMID:40229797

Protective Immunity of a Novel Multi-Epitope Vaccine Encoding OMP31, TF, BLS, SOD, BP26, and L9 Against Brucella spp. Infection., PMID:40223393

Establishment of an I-ELISA method based on multi-epitope fusion protein for diagnosis of human brucellosis., PMID:40193524

Development and Bayesian analysis of a competitive inhibition ELISA for caprine brucellosis., PMID:40179631

Ghostbuster-A Western Blot-Based Panel Method to Resolve False-Positive Brucellosis Serology Test Results., PMID:40142466

Fluorescent bead-based multiplex assays improve serological disease diagnostics and have potential of identifying sensitive immune biomarkers for maintaining health and performance., PMID:40096826

Immune response and protective efficacy of an experimentally developed inactivated oil adjuvant Brucella abortus vaccine in BALB/c mice., PMID:40013279

Preliminary Investigation Towards a Safety Tool for Swine Brucellosis Diagnosis by a Proteomic Approach Within the One-Health Framework., PMID:40003983

Some zoonotic infectious diseases are prevalent among children under 15 years of age in Ardabil Province, northern Iran., PMID:39984836

A comparison between adjuvant and delivering functions of iron oxide and calcium phosphate nanoparticles, using a model protein against Brucella melitensis., PMID:39927221

Seroprevalence of brucellosis in camels and humans in the Al-Qassim region of Saudi Arabia and its implications for public health., PMID:39918760

Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection., PMID:39902052

Preparation and evaluation of Brucella T4SS recombinant proteins in serodiagnosis of human brucellosis based on TMT-based proteomics technology., PMID:39885966

Preparation and application of a Brucella multiepitope fusion protein based on bioinformatics and Tandem Mass Tag-based proteomics technology., PMID:39867886

Serological Diagnosis of Brucella Infection in Cetaceans by Rapid Serum Agglutination Test and Competitive ELISA with Brucella abortus and Brucella ceti as Antigens., PMID:39860987

Bayesian Estimation of the True Bovine Brucellosis Prevalence in Vaccinated and Non-Vaccinated Ecuadorian Cattle Populations, and the Sensitivity and Specificity of a Competitive and Indirect ELISA Using a New Synthetic Antigen., PMID:39858837

Comparison of Long-Term Antibody Titers in Calves Treated with Different Conjunctival and Subcutaneous Brucella abortus S19 Vaccines., PMID:39858212

Development and evaluation of the recombinant BP26 protein-based C-ELISA for human brucellosis diagnosis., PMID:39831112

Validation of an in house iELISA for serodiagnosis of caprine brucellosis and evaluation of the performance of a B. neotomae lysate for the detection of anti-smooth Brucella specific antibodies in ruminants., PMID:39826311

Immunoinformatic design of a multivalent vaccine against Brucella abortus and its evaluation in a murine model using a DNA prime-protein boost strategy., PMID:39640259

Comparative assessment of brucellosis detection in dogs: In-house ELISA versus Rose Bengal Plate Test utilizing rough and smooth antigens., PMID:39612866

Combination application of Pickering emulsion and BLS protein nanoparticles enhances vaccine efficacy., PMID:39547601

Investigation of surfactant apoproteins and Brucella sp. antigens in the lungs of aborted bovine fetuses and neonatal calves delivered weak., PMID:39531869

Development of a colloidal gold immunochromatographic test strip for detecting the smooth Brucella., PMID:39443541

A Thermosensitive and Degradable Chitin-Based Hydrogel as a Brucellosis Vaccine Adjuvant., PMID:39408526

Combined and rapid detection of anti-Brucella IgG/IgM in clinical samples based on surface-enhanced Raman scattering-lateral flow immunochromatography., PMID:39354876

Immunogenicity of Brucella Trivalent Immunogen-Containing Polyethyleneimine Nanostructure Targeted with LPS in a Mouse Model., PMID:39343859

Applying a Fluorescence Polarization Assay for Detection of Brucellosis in Animals Using the Fluorescently Labeled Synthetic Oligosaccharides as Biosensing Tracer., PMID:39194633

Development and Application of Colloidal Gold Test Strips for the Rapid Detection of Canine Brucellosis., PMID:39194617

Intranasal and intraperitoneal immunization against Brucella infection using niosome and mannosylated niosomes containing Brucella recombinant trigger factor/Bp26/Omp31 chimeric protein in a mouse model., PMID:39144123

Beyond its preferential niche: Brucella abortus RNA down-modulates the IFN-γ-induced MHC-I expression in epithelial and endothelial cells., PMID:38980867

New synthesis of oligosaccharides modelling the M epitope of the Brucella O-polysaccharide., PMID:38974993

Development and Bayesian validation of a competitive inhibition ELISA for detection of antibodies against Brucella abortus in cattle., PMID:38972562

Production and evaluation of anti-BP26 monoclonal antibodies for the serological detection of animal brucellosis., PMID:38957801

Construction of recombinant Omp25 or EipB protein loaded PLGA nanovaccines for Brucellosis protection., PMID:38917779

A novel vaccine strategy against Brucellosis using Brucella abortus multi-epitope OMPs vaccine based on Lactococcus lactis live bacterial vectors., PMID:38703567

The immunostimulatory roles of gold nanoparticles in immunization and vaccination against Brucella abortus antigens., PMID:38652965

Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice., PMID:38573916

Contrasting roles for IgM and B-cell MHCII expression in Brucella abortus S19 vaccine-mediated efficacy against B. melitensis infection., PMID:38349167

Design of an oral vaccine using Lactococcus lactis against brucellosis: an in vitro and in vivo study., PMID:38170414

Use of recombinant malate dehydrogenase (MDH) and superoxide dismutase (SOD) [CuZn] as antigens in indirect ELISA for diagnosis of bovine brucellosis., PMID:38101579

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Brucella A antigen Antibody (YsT9.1) [RXX16001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only